Identification, Antioxidant and Immunomodulatory Activities of a Neutral Exopolysaccharide from Lactiplantibacillus plantarum DMDL 9010
Nutrients · 2025
DOI: 10.3390/nu17142265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yanyan Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Intelligent Food Manufacturing, College of Food Science and Engineering, Foshan University, Foshan 528225, Chi…. Hauptthemen laut MEDLINE: Polysaccharides, Bacterial, Antioxidants, Immunologic Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Key Research and Development Program, the Key Laboratory Project of Guangdong Province, Guangzhou Science and Technology, Programme Project Key R&D Special Project.
Abstract (Originalsprache)
Objectives
This study investigated the properties of a neutral exopolysaccharide (EPS-LP1) with an average molecular weight of 55,637 Da, isolated from Lactiplantibacillus plantarum DMDL 9010 (LP9010).
Results
The composition of EPS-LP1 includes galactose (Gal), glucose (Glu) and mannose (Man) in a molar ratio of 5.35:86.25:8.40. Notably, EPS-LP1 exhibits a smooth and rod-like surface along with thermal stability. Methylation combined with nuclear magnetic resonance analysis revealed that EPS-LP1 structured as t-Galp(1→, →6)-Glcp(1→, 4)-Glcp(1→ and →4,6)-Galp(1→), with relative molar ratio of 1.016:9.874:4.355:78.693:6.062, respectively. In the concentration range of 50 to 400 mg/mL, we observed the absence of cytotoxic effects from EPS-LP1 on RAW264.7 cells. Furthermore, EPS-LP1 demonstrated protective effects on RAW264.7 cells against oxidative damage by reducing the production of reactive oxygen species (ROS), malondialdehyde (MDA), and lactate dehydrogenase (LDH) release. Conversely, an increase in superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and concentrations of glutathione (GSH) was observed. Immunoreactivity assays indicated that EPS-LP1 can effectively reduce the production of nitric oxide (NO) and inhibit the secretion of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Additionally, it inhibited the activation of the mitogen-activated protein kinase (MAPK)/nuclear factor-kappa B gene binding (NF-kB) signaling pathway.
Conclusions
This research provides a foundation basis for further investigations into the neutral exopolysaccharide derived from LP9010.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Intelligent Food Manufacturing, College of Food Science and Engineering, Foshan University, Foshan 528225, China.
- School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
ORCID-Profile: Yanyan Huang, Jie Xiong, Xiangze Jia
Förderung
- Guangdong Provincial Key Research and Development Program
- the Key Laboratory Project of Guangdong Province
- Guangzhou Science and Technology, Programme Project Key R&D Special Project
- Guangdong Province Rural Revitalisation Strategy and Special Funds Seed Industry Revitalisation Project
Zitieren
APA
Huang, Y., Liang, W., Lu, Y., Xiong, J., Liu, D., & Jia, X. (2025). Identification, Antioxidant and Immunomodulatory Activities of a Neutral Exopolysaccharide from Lactiplantibacillus plantarum DMDL 9010. Nutrients. https://doi.org/10.3390/nu17142265
Vancouver
Huang Y, Liang W, Lu Y, Xiong J, Liu D, Jia X. Identification, Antioxidant and Immunomodulatory Activities of a Neutral Exopolysaccharide from Lactiplantibacillus plantarum DMDL 9010. Nutrients. 2025. doi:10.3390/nu17142265
BibTeX
@article{Huang2025,
author = {Huang, Yanyan and Liang, Weiting and Lu, Yunhui and Xiong, Jie and Liu, Dongmei and Jia, Xiangze},
title = {Identification, Antioxidant and Immunomodulatory Activities of a Neutral Exopolysaccharide from Lactiplantibacillus plantarum DMDL 9010},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17142265}
}
EUVIMED